Literature DB >> 15035007

The role of sexually transmitted diseases in HIV transmission.

Shannon R Galvin1, Myron S Cohen.   

Abstract

More than 42 million people worldwide are now infected with HIV, in spite of sustained prevention activities. Although the spread of HIV has been primarily sexual, epidemiological studies have indicated that the efficiency of the spread of HIV is poor, perhaps as infrequently as 1 in every 1,000 episodes of sexual intercourse. However, sexually transmitted diseases (STDs) that cause ulcers or inflammation greatly increase the efficiency of HIV transmission--by increasing both the infectiousness of, and the susceptibility to HIV infection. STDs might be particularly important in the early stages of a localized HIV epidemic, when people with risky sexual behaviour are most likely to become infected. In China, eastern Europe and Russia, there has been a remarkable increase in the incidence of STDs in recent years, and this is reflected in the rapid increase in the spread of HIV in these areas. Targeted STD detection and treatment should have a central role in HIV prevention in these emerging epidemics.

Entities:  

Mesh:

Year:  2004        PMID: 15035007     DOI: 10.1038/nrmicro794

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN: 1740-1526            Impact factor:   60.633


  325 in total

1.  Overview of a gay men's STI/HIV testing clinic in Ottawa: clinical operations and outcomes.

Authors:  Patrick O'Byrne; Paul MacPherson; Andrew Ember; Marie-Odile Grayson; Andree Bourgault
Journal:  Can J Public Health       Date:  2014-09-15

2.  Rapid divergence of two classes of Haemophilus ducreyi.

Authors:  Emily E Ricotta; Nan Wang; Robin Cutler; Jeffrey G Lawrence; Tricia L Humphreys
Journal:  J Bacteriol       Date:  2011-04-22       Impact factor: 3.490

3.  Key Concepts in the Early Immunology of HIV-1 Infection.

Authors:  Basile Siewe; Alan Landay
Journal:  Curr Infect Dis Rep       Date:  2012-02       Impact factor: 3.725

4.  Herpes viruses and HIV-1 drug resistance mutations influence the virologic and immunologic milieu of the male genital tract.

Authors:  Sara Gianella; Sheldon R Morris; Christy Anderson; Celsa A Spina; Milenka V Vargas; Jason A Young; Douglas D Richman; Susan J Little; Davey M Smith
Journal:  AIDS       Date:  2013-01-02       Impact factor: 4.177

Review 5.  Immunobiology of genital tract trauma: endocrine regulation of HIV acquisition in women following sexual assault or genital tract mutilation.

Authors:  Mimi Ghosh; Marta Rodriguez-Garcia; Charles R Wira
Journal:  Am J Reprod Immunol       Date:  2012-10-04       Impact factor: 3.886

6.  Estimating Human Immunodeficiency Virus (HIV) Prevention Effects in Low-incidence Settings.

Authors:  Jacqueline E Rudolph; Stephen R Cole; Joseph J Eron; Angela D Kashuba; Adaora A Adimora
Journal:  Epidemiology       Date:  2019-05       Impact factor: 4.822

7.  Evaluation of PD 404,182 as an anti-HIV and anti-herpes simplex virus microbicide.

Authors:  Ana M Chamoun-Emanuelli; Michael Bobardt; Bernard Moncla; Marie K Mankowski; Roger G Ptak; Philippe Gallay; Zhilei Chen
Journal:  Antimicrob Agents Chemother       Date:  2013-11-11       Impact factor: 5.191

8.  HIV Care and Viral Load Suppression After Sexual Health Clinic Visits by Out-of-Care HIV-Positive Persons.

Authors:  Olga Tymejczyk; Kelly Jamison; Preeti Pathela; Sarah Braunstein; Julia A Schillinger; Denis Nash
Journal:  AIDS Patient Care STDS       Date:  2018-10       Impact factor: 5.078

9.  Sociodemographic and behavioral correlates of anogenital warts and human papillomavirus-related knowledge among men who have sex with men and transwomen in Lima, Peru.

Authors:  Brandon Brown; Emmi Monsour; Jeffrey D Klausner; Jerome T Galea
Journal:  Sex Transm Dis       Date:  2015-04       Impact factor: 2.830

10.  Evaluation of WLBU2 peptide and 3-O-octyl-sn-glycerol lipid as active ingredients for a topical microbicide formulation targeting Chlamydia trachomatis.

Authors:  M C Skinner; A O Kiselev; C E Isaacs; T A Mietzner; R C Montelaro; M F Lampe
Journal:  Antimicrob Agents Chemother       Date:  2009-12-14       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.